Molecular Devices Introduces Integrated Microplate Washer and Four-Fluid Dispenser

Molecular Devices Introduces Integrated Microplate Washer and Four-Fluid
Dispenser 


SUNNYVALE, Calif., Feb. 12  /PRNewswire-FirstCall/ -- Molecular Devices
Corporation  today announced the introduction of the AquaMax(R) DW4 liquid
handling system to their expanding line of liquid handling products. The system
integrates four-fluid dispensing and washing into one compact instrument. The
AquaMax DW4 is the only system to handle 1536-well washing, as well as 96- and
384-well low-volume formats. Developed for life scientists and drug discovery
researchers, the system provides better results with adherent and non-adherent
cell lines and beads, and improved productivity over current dispensers.
Windows(R)-compatible software gives the user the flexibility to easily program
multiple dispense and wash procedures.

Commenting on the introduction, Dr. Stephen J. Oldfield, Vice President of
Worldwide Marketing at Molecular Devices stated, "ELISAs, kinase, phosphatase,
and GPCR-type assays that require washing and multiple dispensing steps can now
be done on one compact unit -- there is no need for multiple instruments. The
small footprint saves valuable space in the lab and the system's low-volume
dispense capability saves in costly reagent usage -- for 384-well low-volume
microplates, dispensing has been optimized down to 0.5 microliter. Furthermore,
the user can easily expand throughput capabilities by upgrading from 96-well
through 1536-well in one system."

Molecular Devices Corporation is a leading supplier of high-performance
bioanalytical measurement systems that accelerate and improve drug discovery and
other life sciences research.  The Company's systems and consumables enable
pharmaceutical and biotechnology companies to leverage advances in genomics,
proteomics and combinatorial chemistry by facilitating the high-throughput and
cost-effective identification and evaluation of drug candidates.  The Company's
solutions are based on its advanced core technologies that integrate its
expertisein engineering, molecular and cell biology and chemistry.  Molecular
Devices enables its customers to improve research productivity and
effectiveness, which ultimately accelerates the complex process of discovering
and developing new drugs.

This pressrelease contains "forward-looking" statements, including statements
related to the prospects for or potential customer use of the AquaMax(R) DW4
liquid handling system. Any statements contained in this press release that are
not statements of historical fact may be deemed to be forward-looking
statements. Words such as "believes," "anticipates," "plans," "expects," "will,"
and similar expressions are intended to identify forward-looking statements.
There are a number of important factors that could cause the results of
Molecular Devices Corporation to differ materially from those indicated by these
forward-looking statements, including, among others, risks detailed from time to
time in the Company's SEC reports, including its Annual Report on Form 10-K for
the year ended December 31, 2002 and its quarterly report on Form 10-Q for the
quarter ended September 30, 2003. Molecular Devices Corporation does not
undertake any obligation to update forward-looking statements. 

DATASOURCE: Molecular Devices Corporation



CONTACT:  Tim Harkness of Molecular Devices Corporation, [phone]



Web site:  http://www.moleculardevices.com/ 

Copyright